Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples